ALS News & Research For postings of news or research links and articles related to ALS


advertisement
Reply
 
Thread Tools Display Modes
Old 03-10-2017, 03:35 AM #1
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
 
Join Date: Feb 2007
Posts: 3,266
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,266
15 yr Member
Exclamation AveXis to Present Results from Phase 1 Trial of AVXS-101 in SMA Type 1 at AAN Annual

AveXis to Present Results from Phase 1 Trial of AVXS-101 in SMA Type 1 at AAN Annual Meeting

http://finance.yahoo.com/news/avexis...210500463.html
MuonOne is offline   Reply With QuoteReply With Quote

advertisement
Reply

Tags
aan, annual, avxs-101, sma, type

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
DM-1992 / Depomed Reports Encouraging Results of its Phase I Trial Stitcher Parkinson's Disease 0 08-12-2009 06:48 AM
DM-1992 / Depomed Reports Encouraging Results of its Phase I Trial Stitcher Parkinson's Disease Clinical Trials 0 08-12-2009 06:47 AM
CERE-120 phase II trial results - shocking jeanb Parkinson's Disease 17 12-08-2008 10:43 AM
Six-Month Efficacy Results With Low Dose of ProSavin in Phase I/II Trial Stitcher Parkinson's Disease 1 11-21-2008 11:08 AM


All times are GMT -5. The time now is 02:24 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.